Johnson & Johnson enters late-stage trial testing its coronavirus vaccine

J&J is the fourth drugmaker backed by the Trump's administration's Covid-19 vaccine program Operation Warp Speed to enter late-stage testing.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.